Evidence map›Paper›PMID 26919738›Full record

ArticleAIDS (London, England)2016

Longitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapy.

Claudia Nobrega, Ana Horta, Vítor Coutinho-Teixeira, Ana Martins-Ribeiro, Ana Baldaia, Rita Rb-Silva, Catarina L Santos, Rui Sarmento-Castro, Margarida Correia-Neves

Open access · hybridAbstract read
In one paragraph

Article in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Changes in the Regulatory T-Lymphocyte Counts in HIV-Infected Patients with a Discordant Response to Antiretroviral Therapy.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2019
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Claudia NobregaaLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga bICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães cInfectious Diseases Service of the Centro Hospitalar do Porto, Hospital Joaquim Urbano Unit, Porto, Portugal. *Claudia Nobrega and Ana Horta contributed equally to the writing of this article.
Ana Horta
Vítor Coutinho-Teixeira
Ana Martins-Ribeiro
Ana Baldaia
Rita Rb-Silva
Catarina L Santos
Rui Sarmento-Castro
Margarida Correia-Neves
Creative Commons · USFundación Juan March · ESUniversity of Minho · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesA sizeable percentage of individuals infected by HIV and on antiretroviral therapy (ART) fail to increase their CD4 T-cells to satisfactory levels. The percentage of regulatory T-cells (Tregs) has been suggested to contribute to this impairment. This study aimed to address this question and to expand the analysis of Tregs subpopulations during ART.

designLongitudinal follow-up of 81 HIV-infected individuals during the first 24 months on ART.

methodsCD4 T-cell counts, Tregs percentages, and specific Tregs subpopulations were evaluated at ART onset, 2, 6, 9, 12, 16, 20, and 24 months of ART (five individuals had no Tregs information at baseline).

resultsThe slope of CD4 T-cell recovery was similar for individuals with moderate and with severe lymphopenia at ART onset. No evidence was found for a contribution of the baseline Tregs percentages on the CD4 T-cell counts recovery throughout ART. In comparison to uninfected individuals, Tregs percentages were higher at ART onset only for patients with less than 200 cells/μl at baseline and decreased afterwards reaching normal values. Within Tregs, the percentage of naive cells remained low in these patients. Reduced thymic export and increased proliferation of Tregs vs. conventional CD4 T cells might explain these persistent alterations.

conclusionNo effect of Tregs percentages at baseline was detected on CD4 T-cell recovery. However, profound alterations on Tregs subpopulations were consistently observed throughout ART for patients with severe lymphopenia at ART onset.

Indexed as

Immunity, CellularAdultAgedAnti-Retroviral AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedTime FactorsT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsYoung AdultAnti-Retroviral Agents

Identifiers

PMID26919738
PMCPMC4856178
OpenAlexW2313317895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.